SO ERIC H. L. (Executive Chair) purchased 2.3% of their position (100K shares) of HELUS PHARMA INC. on the open market
Open‑market purchase worth $1.21M — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 9/10/2026ACC: 0000912282-26-001257
DirectorOfficer· Executive Chair
Since Sep 2026
+100K
Net shares
Net buyer
$1.21M
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
100K acquired
Non-Derivative Transactions1
Common Shares
Direct
Shares
+100K
Price / share
$12.09
Trade value
$1.21M
% of position
2.3%
9/4/2026
4.27M→4.37M
Total
Net shares
+100K
Net value
$1.21M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 9/4/2026 | P · Purchase | +100K | $12.09 | $1.21M | 2.3% | 4.27M | 4.37M |
| Total | +100K | $1.21M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Shares
IndirectShares owned53.62K
Total
53.62K indirect53.62K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Shares | 53.62K | Indirect |
| Total | 53.62K | 53.62K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported